Xeris Biopharma Holdings, Inc. (XERS)

Typically moves ±9.05% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Since Nov 10, 2021, Xeris Biopharma Holdings, Inc. (XERS) has reported earnings 20 times. On average the shares move ±9.05% post-earnings, with a positive reaction 55.0% of the time. Its largest post-earnings gain was +20.22% (Aug 07, 2025) and its largest decline was -21.88% (Nov 06, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How XERS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±9.05%

Positive %

55.0%

Negative %

45.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☀ PRE	-9.36%	open_in_new
May 07, 2026	☀ PRE	+4%	open_in_new
Mar 02, 2026	☀ PRE	-1.63%	open_in_new
Nov 06, 2025	☀ PRE	-21.88%	open_in_new
Aug 07, 2025	☀ PRE	+20.22%	open_in_new
May 08, 2025	☀ PRE	+15.18%	open_in_new
Mar 06, 2025	☀ PRE	+9.55%	open_in_new
Nov 08, 2024	☀ PRE	+3.27%	open_in_new
Aug 08, 2024	☀ PRE	+4.69%	open_in_new
May 09, 2024	☀ PRE	+1.62%	open_in_new
Mar 06, 2024	☀ PRE	-19.48%	open_in_new
Nov 09, 2023	☀ PRE	-8.59%	open_in_new
Aug 08, 2023	☀ PRE	+3.61%	open_in_new
May 09, 2023	☀ PRE	+13.75%	open_in_new
Mar 08, 2023	☀ PRE	-11.76%	open_in_new
Nov 09, 2022	☀ PRE	-1.33%	open_in_new
Aug 10, 2022	☀ PRE	+13.53%	open_in_new
May 11, 2022	☀ PRE	-8.38%	open_in_new
Mar 10, 2022	☀ PRE	+6.07%	open_in_new
Nov 10, 2021	☀ PRE	-3.06%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.05%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 25 →

Funds holding

$258906533

Total value held

Buying

20 added · 5 reduced

Blackrock, Inc.

$115042270 +12.20%

State Street Corp

$38186803 +3.51%

Morgan Stanley

$18509800 -9.16%

Northern Trust Corp

$12654172 +10.60%

Goldman Sachs Group Inc

$12625051 -1.21%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260901	open_in_new SEC.gov
4	20260901	open_in_new SEC.gov
4	20260901	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
4	20260821	open_in_new SEC.gov
144	20260812	open_in_new SEC.gov
4	20260812	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov

Frequently asked about XERS earnings

When does Xeris Biopharma Holdings, Inc. report earnings next? expand_more

Xeris Biopharma Holdings, Inc. (XERS)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does XERS stock move after earnings? expand_more

Over 20 reports, XERS has moved an average of ±9.05% the session after earnings, closing higher 55.0% of the time.

What was XERS's biggest post-earnings move? expand_more

XERS's largest post-earnings gain on record was +20.22% on Aug 07, 2025, and its largest decline was -21.88% on Nov 06, 2025.

Where can I find Xeris Biopharma Holdings, Inc.'s SEC filings? expand_more

All of Xeris Biopharma Holdings, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.